Thomson Reuters

Newport Vision SourcingTM is an expert sourcing and competitive intelligence system for innovator, niche brand, and specialty pharmaceutical companies.

Powered by unique early intelligence and analysis available only from Thomson, the industry authority on global API (Active Pharmaceutical Ingredient) development activities, Newport Vision Sourcing  contains detailed profiles of close to 10,000 active ingredients, 12,000 corporate groups and 3,000 API production sites worldwide.

Expert competitive intelligence on the global generic market.

With Newport Vision Sourcing, you can:

• Identify alternative, potentially lower-cost sources of API supply for existing products.
• Determine potential suppliers for new products based on specific technical and manufacturing capabilities and past history.
• Assess generic competition and identify potential suppliers to generic companies
• Monitor patenting activities of API manufacturers worldwide.
• Investigate products and analyze patent, exclusivity and regulatory information.

Why choose Newport Vision Sourcing?

• Unique early API development intelligence and competitive forecasts.
• Coverage of close to 10,000 active pharmaceutical ingredients.
• Worldwide patent families and patents by country filed by innovators, API manufacturers, and generic companies together with US and European exclusivities.
• US Drug Master File, Orange Book and European Certificate of Suitability data.
• Chemical structures and potential routes of synthesis.
• Profiles of 12,000 corporate groups and 3,000 API facilities including detailed manufacturing capabilities for an increasing number of producers.

• Monthly data updates.
• Intuitive, easy-to-use web technology.
• Comprehensive training and technical support.
• Flexible licensing options.
• Zero cost deployment.
• Secure, confidential access.